Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Hyaluronic Acid for Subdeltoid Bursitis

NCT: NCT07729527 · NOT_YET_RECRUITING

NCT IDNCT07729527
StatusNOT_YET_RECRUITING
Start Date2026-07-31
Completion2026-12-31
SponsorShin Kong Wu Ho-Su Memorial Hospital (OTHER)
First posted
Last updated

Brief Summary

The study employs a double-blind, randomized clinical trial design with 50 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: with either cross-linked hyaluronic acid or non-crossed-linked hyaluronic acid injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑